.png)
.png)
TOPLINE: High-resolution microultrasonography-guided biopsy was non-inferior to MRI fusion-guided biopsy for detecting clinically significant prostate cancer (detection rates, 47.1% and 42.6%, respectively), a new trial showed. METHODOLOGY: This multicentre, open-label, randomised, non-inferiority trial across eight countries, conducted from 2021 to 2024, included biopsy-naive adult men with clinical suspicion of prostate cancer due to elevated prostate-specific ...
Copyright © 2024 buzzstream. All Rights Reserved
Copyright © 2024 BuzzStream. All Rights Reserved.
All content on this website, including but not limited to text, images, graphics, logos, articles, and other materials, is the property of BuzzStream and is protected by international copyright laws. No part of this content may be reproduced, distributed, transmitted, displayed, published, or broadcast without BuzzStream's prior written permission. Unauthorized use of the content is strictly prohibited and may result in legal action.
For inquiries regarding the use or licensing of content, please contact us at 1-832-482-2215.
Feel free to customize it further if needed!
